Structure Therapeutics Inc. - GPCR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 2.6% 5,583,855 View
Feb 17, 2026 SCHEDULE 13G/A BVF I GP LLC 2.6% 5,583,855 View
Feb 17, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 1.9% 4,053,954 View
Feb 17, 2026 SCHEDULE 13G/A BVF II GP LLC 1.9% 4,053,954 View
Feb 17, 2026 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.3% 643,536 View
Feb 17, 2026 SCHEDULE 13G/A BVF Partners OS Ltd. 0.3% 643,536 View
Feb 17, 2026 SCHEDULE 13G/A BVF GP HOLDINGS LLC 4.5% 9,637,809 View
Feb 17, 2026 SCHEDULE 13G/A BVF PARTNERS L P/IL 4.9% 10,437,066 View
Feb 17, 2026 SCHEDULE 13G/A BVF INC/IL 4.9% 10,437,066 View
Feb 17, 2026 SCHEDULE 13G/A LAMPERT MARK N 4.9% 10,437,066 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Capital, LP 5.95% 12,335,346 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 5.95% 12,335,346 View
Feb 13, 2026 SCHEDULE 13G/A David Kroin 5.95% 12,335,346 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Group LLP 10.1% 21,365,952 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 10.1% 21,365,952 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 10.1% 21,365,952 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Company LLP 9.6% 21,365,952 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 15.0% 31,112,634 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 15.0% 31,112,634 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.